Inventor

JACOBSON KENNETH A

US56 patents

⚠️ This page may combine multiple inventors who share the name “JACOBSON KENNETH A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JACOBSON KENNETH A

US HEALTH

Methanocarba cycloakyl nucleoside analogues

Adenosine receptor prodrugs

A3 adenosine receptor agonists

Biologically-active xanthine derivatives

Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists

Dihydropyridine-, pyridine-, benzopyran-4-one- and triazoloquinazoline derivative, their preparation and their use as adenosine receptor antagonists

A3 adenosine receptor agonists

Molecular probes for adenosine receptors

Biologically-active 1,3-dipropyl-8-phenylxanthine derivatives

S-substituted 1,3,7-trialkyl-xanthine derivatives

Process for introducing fluorine into biologically active materials

Derivatization of amines for electrochemical detection

Methanocarba cycloalkyl nucleoside analogues

A3 adenosine receptor agonists

Purine derivatives as A3 and A1 adenosine receptor agonists

A3 adenosine receptor antagonists

Xanthines for identifying CFTR--binding compounds useful for activating chloride conductance in animal cells

A3 adenosine receptor agonists

Sulfur-containing xanthine derivatives as adenosine antagonists

Method of treating cystic fibrosis using 8-cyclopentyl-1,3-dipropylxanthine or xanthine amino congeners

US ARMY

Biologically active ATP analogs

Irreversible inhibitors of adenosine receptors

Irreversible inhibitors of adenosine receptors

2-substituted adenosines and 2-substituted adenosine 5&#39;-carboxamides

Muscarinic antagonists

Adenosine functionalized congeners as cardiovascular treating agents for animals and methods for using same

Sulfo-derivatives of adenosine

Trifunctional agents useful as irreversible inhibitors of A1-adenosine receptors

N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl]amide congeners as muscarinic agents

JACOBSON KENNETH A

Lower unit guard

Adenosine receptor agonists, partial agonists, and antagonists

A3 adenosine receptor agonists and antagonists

Methanocarba adenosine derivatives, pharmaceutical compositions, and method of reducing intraocular pressure

Purine derivatives as A3 adenosine receptor-selective agonists

A3 adenosine receptor antagonists and partial agonists

UNIV PENNSYLVANIA

Methods for reducing ischemic injury of the heart via the sequential administration of monophosphoryl lipid A and adenosine receptor agents

Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists

Methods for reducing intraocular pressure using A3 adenosine receptor antagonists

Methods for protecting against cardiac ischemia by administering adenosine A2a receptor antagonists

UNIV CONNECTICUT

Compositions and methods to treat cardiac diseases

Compositions and methods to treat cardiac diseases

Methods of treating heart failure with modified ATP, ADP and AMP compounds

Methods for pharmacologic treatment of stroke

UNIV VIRGINIA

Substituted 8-phenylxanthines useful as antagonists of A2B adenosine receptors

LIANG BRUCE

Compositions and methods to treat cardiac diseases

EWHA WOMANS UNIVERSITY

Purine nucleosides

UNIV CALIFORNIA

Biologically active catecholamine derivatives

US DEPARTMANT OF HEALTH AND HU

Method of treating ischemic, hypoxic and anoxic brain damage

JEONG LAK SHIN

Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient

ASTROCYTE PHARMACEUTICALS INC

Compounds and methods for treating neurological and cardiovascular conditions

2-substituted adenosines and 2-substituted adenosine 5'-carboxamides